Skip to content

Faculty profile

Fiona Smaill

Back to faculty
Professor EmeritusPathology & Molecular MedicineMcMaster University

Research

Research areas, by share of publications

Research areas are derived from OpenAlex topics of their publications.

From the 150 most recent of 182 publications.

01

Incidence and Prevalence of Human Papillomavirus Infection to Predict Outcomes from HPV-Based Cervical Cancer Screening in Women and People with a Cervix Living with HIV

Nicolls S, McClymont E, Lee M, Coutlée F, Trottier S, Smaill F, Loutfy M, Yudin MH, Klein MB, Harris M

Journal of acquired immune deficiency syndromes (1999)2026
DOI: 10.1097/qai.0000000000003902
02

Microbiome analysis of bronchoalveolar lavage (BAL) specimens from immunocompromised patients with pneumonia compared to those from healthy volunteers

Fatima Z, Surette MD, Marttala S, Leto D, Jayaratne P, Smaill F, Smieja M, Hasan MR

PLoS ONE2026
DOI: 10.1371/journal.pone.0351562
03

Vascular risk drives cognitive decline over 10 years in people aging with well-controlled HIV.

Brouillette M-J, Scott SC, Harris M, Thomas R, Smaill F, Smith G, Haider S, Letendre SL, Fellows LK, Mayo NE

AIDS2026
DOI: 10.1097/qad.0000000000004576
04

Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trial

Jeyanathan M, Afkhami S, D’Agostino MR, Satia I, Fritz DK, Miyasaki K, Ang JC, Zganiacz A, Howie KJ, Swinton M

Nature Communications202521 citations
DOI: 10.1038/s41467-025-60726-0
05

Feasibility, safety and tolerability of estrogen and/or probiotics for improving vaginal health in Canadian African, Caribbean, and Black women: A pilot phase 1 clinical trial

Gill B, Wessels JM, Hayes CL, Ratcliffe J, Wokuri J, Ball E, Reid G, Kaul R, Rana J, Alkhaifi M

PLoS ONE20255 citations
DOI: 10.1371/journal.pone.0315576
06

AeroVax: study protocol for a randomised, double-blind, placebo-controlled, phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans

Komorowski AS, Mbuagbaw L, Jeyanathan M, Afkhami S, Swinton M, D'Agostino MR, Howie K, Medina MFC, Gauvreau GM, Brister DL

ERJ Open Research20251 citations
DOI: 10.1183/23120541.00758-2024
07

The association between HIV drug resistance testing, viral suppression and mortality in Ontario: a retrospective cohort study

Mbuagbaw L, Logie CH, Thabane L, Smaill F, Smieja M, Burchell AN, Rachlis B, Tarride JE, Kroch AE, Mazzulli T

HIV Medicine2025
DOI: 10.1111/hiv.70086
08

Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials

Orkin C, Molina J-M, Cahn P, Lombaard J, Supparatpinyo K, Kumar S, Campbell H, Wan H, Teal V, Xu ZJ

The Lancet HIV202437 citations
DOI: 10.1016/s2352-3018(23)00258-8
09

BEING: Bone Health in Aging Women with HIV: Impact of Switching Antiretroviral Therapy on Bone Mineral Density During the Perimenopausal Period

Walmsley S, Clarke R, Lee T, Singer J, Cheung AM, Smaill F, De Pokomandy A, Trottier S, Messina E, Guaraldi G

AIDS Research and Human Retroviruses20238 citations
DOI: 10.1089/aid.2022.0106
10

Methodological and Reporting Quality of Noninferiority Randomized Controlled Trials Comparing Antiretroviral Therapies: A Systematic Review

Lo CKL, Komorowski AS, Hall CW, Sandstrom TS, Alamer AAM, Mourad O, Li XX, Al Ohaly R, Benoit M-È, Duncan DB

Clinical Infectious Diseases20236 citationsOpen Access
DOI: 10.1093/cid/ciad308PMID: W4378514540

Research institutes and memberships

  • McMaster Immunology Research Centre (MIRC)
  • Michael G. DeGroote Cochrane Canada Centre at McMaster
  • Michael G. DeGroote Institute for Infectious Disease Research (IIDR)
Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for
Subject: Prospective PhD student: HIV/AIDS drug development and treatment Dear Professor Smaill, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Incidence and Prevalence of Human Papillomavirus Infection to Predict Outcomes from HPV-Based Cervical Cancer Screening in Women and People with a Cervix Living with HIV" (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "A phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans" (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]
Open in email

Profile data last refreshed on September 25, 2026 from the university directory, OpenAlex and CIHR.

Something wrong or missing on this profile? Suggest a correction